Drugs: gastrointestinal system

The British Society of Gastroenterology. 1984 annual meeting, Liverpool. Abstracts.
Gut Oct 1984, 25 (10) A1129-A1193; DOI: 10.1136/gut.25.10.A1129
PWE-171 Assessing The Utility Of Key Mri Parameters In Characterising The Mode Of Action Of A Proven Effective Laxative, Ispaghula
K Murray, L Marciani, G Major, C Hoad, E Cox, A Silos-Santiago, C Kurtz, M Kaviani, JA Paul, P Gowland, J Johnston, R Spiller

Gut Jun 2014, 63 (Suppl 1) A200; DOI: 10.1136/gutjnl-2014-307263.431
PWE-176 Prevalence, Management, And Healthcare Burden Of Irritable Bowel Syndrome (ibs) In Scotland
S McTaggart, G Wyper, L Harkins, I Bishop, M Bennie, M Rance

Gut Jun 2014, 63 (Suppl 1) A202-A203; DOI: 10.1136/gutjnl-2014-307263.436
PWE-175 Cost-effectiveness Of Linaclotide (lin) Compared To Antidepressants (atds) In The Treatment Of Irritable Bowel Syndrome With Constipation (ibs-c) In Scotland
M Fisher, A Walker, M Falqués, M Rance, D Taylor, L Lindner

Gut Jun 2014, 63 (Suppl 1) A202; DOI: 10.1136/gutjnl-2014-307263.435
PWE-178 Impact Of Chronic Constipation On Healthcare Resource Use In The Uk: An Analysis Based On Electronic Medical Records
M Radford, E Bloomfield, A Joseph

Gut Jun 2014, 63 (Suppl 1) A203-A204; DOI: 10.1136/gutjnl-2014-307263.438
PTH-087 Fam5C, a Possible Causal Molecule in Ulcerative Colitis Revealed through a Transcriptomic Analysis of the Bowel Mucosa
P J Smith, A P Levine, G W Sewell, N R O’Shea, M Rodriguez-Justo, M R Novelli, R Vega, S L Bloom, A M Smith, A W Segal

Gut Jun 2013, 62 (Suppl 1) A246-A247; DOI: 10.1136/gutjnl-2013-304907.574
PTH-118 Quality of Bowel Preparation for Colonoscopy: can we Learn anything from Patients’ Perspectives?
J Alexander, S Moore, P Neild

Gut Jun 2013, 62 (Suppl 1) A259; DOI: 10.1136/gutjnl-2013-304907.605
PTH-195 Lubiprostone Treatment Improves Constipation and Related Symptoms in Patients Refractory to other Constipation Therapies
R M Panas, T Joswick, P Lichtlen, D Panigrahi, R Ueno

Gut Jun 2013, 62 (Suppl 1) A291; DOI: 10.1136/gutjnl-2013-304907.682
PTU-076 Diagnostic Potential of Volatile Organic Compounds as Faecal Biomarkers in Inflammatory Bowel Disease
H Jayasena, T Khalid, C S Probert

Gut Jun 2013, 62 (Suppl 1) A75-A76; DOI: 10.1136/gutjnl-2013-304907.168
Summary
M Costa, H Glise, H Graffner

Gut Mar 2004, 53 (suppl 2) ii22-ii25; DOI: 10.1136/gut.2003.033472

Main menu

Drugs: gastrointestinal system

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Drugs: gastrointestinal system

Pages